PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)

/PRNewswire/ -- PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it has been...

Related Keywords

Smyrna ,Izmir ,Turkey ,Pennsylvania ,United States ,Americans ,Rob Snyder ,Prnewswire Pantherx ,J Clin Neuromuscul ,Group Of Companies ,Utilization Review Accreditation Commission ,Accreditation Commission For Health Care ,Rare Disease Center ,Ucb Inc ,National Institutes Of Health ,Full Prescribing Information ,Myasthenia Gravis ,Generalized Myasthenia Gravis ,Accreditation Commission ,Health Care ,Orphan Drugs ,Choice Award ,Accessed June ,Rare Disease Facts ,Rare Earns Disease Pharmacy Designation ,Seventh Annual Specialty Pharmacy Patient Choice ,Pantherx Rare Pharmacy ,